antihemophilic

(redirected from antihaemophilic)

antihemophilic

 [an″te-, an″ti-he″mo-fil´ik]
1. effective against the bleeding tendency in hemophilia.
2. an agent that has this effect.

antihemophilic

/an·ti·he·mo·phil·ic/ (-he″mo-fil´ik) counteracting hemophilia, or an agent that so acts.

an·ti·he·mo·phil·ic

(an'tē-hē-mō-fil'ik)
Correcting or counteracting the hemorrhagic tendency in hemophilia.
Synonym(s): antihaemophilic.
[anti- + hemophilic]

antihemophilic

1. effective against the bleeding tendency in hemophilia.
2. an agent that counteracts the bleeding tendency in hemophilia.

antihemophilic factor (AHF) A
one of the clotting factors, deficiency of which causes von willebrand's disease and hemophilia A. Called also factor VIII and antihemophilic globulin.
antihemophilic factor B
clotting factor IX.
antihemophilic factor C
clotting factor XI.
References in periodicals archive ?
The product is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihaemophilic Factor when used to decrease the frequency of bleeding.
Effect of anti-hemophilic factor on one-stage clotting tests: a presumptive test for haemophilia and a simple one stage antihaemophilic factor assay procedure.
Further experience in use of Human Antihaemophilic Globulin (H.
Most blood for transfusion is collected as whole blood (WB), or venous blood with an added preservative, and then separated by centrifugation into different components, such as red blood cells, plasma, cryoprecipitated antihaemophilic factor (AHF), and platelets.
List of biopharmaceuticals that have received approval from MOH as biosimilar Products Name of company 1 IFN alpha Pasteur Institute of Iran, Poyesh Daro 2 G-CSF Poyesh Daro 3 EPO alpha Pasteur Institute of Iran, Poyesh Daro, Notarkib 4 IFN beta 1a CinnaGen, (CinnoVex) 5 IFN beta 1a CinnaGen (ReciGen) 6 Epo beta CinnaGen, Zahravi 7 PTH CinnaGen 8 Buscerlin CinnaGen 9 Interferon beta 1b Zist daro Danesh 10 Interferon gamma NoTarkib 11 Peg-Interferon alpha Poyesh Daro 12 Antihaemophilic AryoGen factor VII 13 HBS (Vaccine) Pasteur Institute Table 3.
High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate.
Tenders are invited for Inj Antihaemophilic Factor Human Method M Monoclonal Purified Fviii 250 Iu
Tenders are invited for TENDER ENQUIRY FOR PURCHASE OF INJECTION ANTIHAEMOPHILIC FACTOR-VII, VIII & IX FOR GENERAL HOSPITAL, MEHSANA.
Tenders are invited for Drug antihaemophilic factor viii 250iu